PRESSEMITTEILUNGEN

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Berlin, Germany, and Seattle, WA, U.S.A., January 4, 2012 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, is pleased to announce that it has submitted [...]

Continue reading

American Cancer, Approval Application, Berlin Germany, Colorectal Cancer, Document Guidance, Epigenomics Ag, Fda Staff, Food And Drug Administration, Food And Drug Administration Fda, Guidance Document, Inferiority, Molecular Diagnostics, Premarket Approval, Prime Standard, Quality Controls, Regulatory Approval, Screening Test, Study Protocol, Submission Protocol, Us Food And Drug Administration

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– New Products/molecular diagnostics 09.12.2011 Berlin, Germany, December 9, 2011 – Epigenomics AG (ISIN: DE000A1K0516) reports the completion of the clinical validation study [...]

Continue reading

Berlin Germany, Cancer Cases, Clinical Performance, Clinical Validation, Colonoscopy, Colorectal, Colorectal Cancer, Disease Specificity, Epigenomics Ag, Food And Drug Administration, Food And Drug Administration Fda, German Securities Trading Act, Independent Laboratories, Molecular Diagnostics, Plasma Samples, Regulatory Approval, Screening Guidelines, Securities Trading Act, Study Subjects, Validation Study

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Subtitle: Conference Call Scheduled for today, 9thDecember 2011 at 4 pm CET Berlin, Germany, and Seattle, WA, U.S.A., December 9, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer [...]

Continue reading

Adhoc, Berlin Germany, Cancer Cases, Clinical Performance, Clinical Validation, Colonoscopy, Colorectal, Colorectal Cancer, Diagnostic Company, Disease Specificity, Eans, Epigenomics Ag, Independent Laboratories, Molecular Diagnostics, Plasma Samples, Prime Standard, Regulatory Approval, Screening Guidelines, Study Subjects, Validation Study

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products/Company Information/molecular diagnostics Subtitle: Epigenomics to host a corporate workshop on advances in blood-based colorectal cancer screening; ARUP Laboratories will present independent data for its laboratory-developed Septin9 test Grapevine, TX, U.S.A., November 16, 2011 (euro [...]

Continue reading

Adjunct Assistant Professor, American Cancer, Arup Laboratories, Biomarker, Cancer Cases, Cancer Screening, Colorectal Cancer, Corporate Workshop, Epigenomics Ag, Grapevine Texas, Grapevine Tx, Independent Data, Interpretation Algorithm, Ldt, Molecular Diagnostics, Molecular Pathology, Plasma Marker, Test Interpretation, University Of Utah School Of Medicine, Utah School

Thousand Oaks, California, November 15 (ots/PRNewswire) – Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix(R) (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in [...]

Continue reading

Asia 1, Cancer In Women, Chemotherapy Regimens, Colorectal Cancer, Conditional Approval, European Commission Approval, Folfiri, Folfox, Incidence Rates, Irinotecan, Jean Yves, Mcrc, Oxaliplatin, Prnewswire, Professor Jean, Thousand Oaks California, Today Announced That, Treatment Choice, Vectibix, Yves Douillard

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products/Company Information/molecular diagnostics Subtitle: Presentation of the powerful second generation blood test for colorectal cancer screening during UEGW in Stockholm Berlin, Germany, and Stockholm, Sweden, October 25, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime [...]

Continue reading

Adhoc, Berlin Germany, Blood Test, Cancer Detection, Cancer Screening, Clinical Validation, Colorectal, Colorectal Cancer, Epigenomics Ag, European Gastroenterology, Invasive Method, Launch, Molecular Diagnostics, New Test, Positive Predictive Value, Ppv, Prime Standard, Second Generation, Stockholm Sweden, Uegw

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Subtitle: Study provides clinical evidence for CE-marking in Europe and paves way to US pivotal clinical trial for submission to FDA before year-end Berlin, Germany, and Seattle, WA, USA, September 19, 2011 [...]

Continue reading

Adhoc, Ag Reports, Berlin Germany, Cancer Cases, Clinical Evidence, Colonoscopy, Colorectal, Colorectal Cancer, Epigenomics, Food And Drug Administration, Molecular Diagnostics, Pivotal Clinical Trial, Prime Standard, Product Validation, Seattle Wa Usa, Second Generation, Significant Improvement, Specificity, Therapeutic Interventions, Validation Study

Thousand Oaks, California (ots/PRNewswire) – Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Vectibix(R) (panitumumab) be approved for use in the European Union (EU) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI [...]

Continue reading

Aggressive Disease, Amgen, Chemotherapy, Colorectal Cancer, Commission Decision, European Medicines, Folfiri, Folfox, Free Survival, Irinotecan, Medicines Agency, Panitumumab, Prime Study, Prnewswire, Senior Vice President, Statistical Significance, Thousand Oaks California, Today Announced That, Vectibix, Welcome Step

London/Barcelona (ots) – Die europäische Darmkrebspatientenkonferenz “Colorectal Cancer Patient Conference” (CCPC) ist die erste gemeinsame, interdisziplinäre Veranstaltung ihrer Art und wird von Krebsexperten sowie anderen relevanten Meinungsführern aus ganz Europa und den USA getragen. Die am schnellsten wachsende europäische Initiative für Darmkrebspatienten europacolon lädt Patienten, Angehörige, Selbsthilfegruppen, Pflegekräfte und Medizinexperten des ganzen Kontinents zu dieser [...]

Continue reading

Barcelona, Cancer Patient, Colorectal, Colorectal Cancer, Darmkrebs, Ein, Esmo, Ganz Europa, Gastrointestinal, Gastrointestinal Cancer, Initiative, Inspiration, Krankheit, London, Motivation, Ots, Pavel, Vereinigtes Europa, World Congress

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products/Company Information/molecular diagnostic Berlin, Germany, and Seattle, WA, U.S.A., May 6, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer molecular diagnosis company, today announced the signing of a supply agreement with [...]

Continue reading

Automation Solutions, Berlin Germany, Biological Samples, Biomarker, Clinical Performance, Colorectal Cancer, Diagnostic Analysis, Dynabeads, Feasibility Study, Generation Test, Innovative Life, Magnetic Beads, Molecular Diagnosis, Nucleic Acids, Original Equipment Manufacturer, Oslo Norway, Prime Standard, Quality Management Systems, Science Solutions, Silane

Thousand Oaks, California (ots/PRNewswire) – Amgen announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in March by the Committee For Medicinal Products for Human Use (CHMP) for the use of Vectibix in combination with chemotherapy for patients with wild-type KRAS metastatic [...]

Continue reading

Aggressive Disease, Amgen, Chemotherapy, Colorectal, Colorectal Cancer, Ema, European Medicines, Free Survival, Grade 3, Mcrc, Medicines Agency, Ots, Panitumumab, Pfs, Prnewswire, Response Rate, Statistical Significance, Thousand Oaks California, Treatment Option, Vectibix

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– New Products/Molecular diagnostics 28.02.2011 Berlin, Germany, February 28, 2011 – Epigenomics AG (ISIN: DE000A0BVT96) today signed an option agreement in colorectal cancer [...]

Continue reading

Amp, Berlin Germany, Biomarker, Biomarkers, Blood Test, Blood Testing, Collaboration Agreement, Collection Of Clinical Specimens, Colorectal, Colorectal Cancer, Dna Methylation, Epigenomics Ag, German Securities Trading Act, Isin, Molecular Diagnostics, Option Agreement, Qiagen, Sample Preparation, Securities Trading Act, Upfront Payment

QIAGEN acquires options to mSEPT9 biomarker and DNA methylation technologies; QIAGEN granted license to pursue Septin9 product related R&D ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Joint Ventures/Cooperation/Collaboration/New Products/Molecular diagnostics Subtitle: QIAGEN acquires options to mSEPT9 biomarker and DNA methylation technologies; QIAGEN granted [...]

Continue reading

Adhoc, Berlin Germany, Biomarker, Blood Test, Blood Testing, Collaboration Agreement, Colorectal, Colorectal Cancer, Corporate News, Dna Methylation, Epigenomics Ag, Joint Ventures, Molecular Diagnostics, Nasdaq, Option Agreement, Prime Standard, Qgen, Qiagen, Sample Preparation, Seattle Wa Usa

Toronto (ots/PRNewswire) – Die “Colorectal Cancer Association of Canada” (CCAC, kanadische Vereinigung für Kolorektalkrebs) lädt aufstrebende Werbedesigner und Filmemacher ein, ihre Talente einzusetzen, um durch ihre Teilnahme an dem zweiten Jahreswettbewerb “International Public Service Announcement (PSA) Contest” (Ausschreibungswettbewerb für öffentliche Institutionen) weltweit das Bewusstsein für Kolorektalkrebs zu fördern. Neben Bargeldpreisen von bis zu $4.500,- CAD [...]

Continue reading

Association Of Canada, Bowel Cancer, Cancer Association, Cancer Canada, Ccac, Colorectal, Colorectal Cancer, Film Board Of Canada, Inspiration, Kampagne, MäNner Und Frauen, National Film Board, National Film Board Of Canada, Ogilvy Montreal, Ots, Prnewswire, Psa, Psas, Public Service Announcement, Quot